Heartbeam Inc (BEAT) - Net Assets
Based on the latest financial reports, Heartbeam Inc (BEAT) has net assets worth $2.60 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.84 Million) and total liabilities ($3.24 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Heartbeam Inc (BEAT) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.60 Million |
| % of Total Assets | 44.55% |
| Annual Growth Rate | -4.98% |
| 5-Year Change | -80.59% |
| 10-Year Change | -98.13% |
| Growth Volatility | 154.35 |
Heartbeam Inc - Net Assets Trend (2003–2025)
This chart illustrates how Heartbeam Inc's net assets have evolved over time, based on quarterly financial data. See Heartbeam Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Heartbeam Inc (2003–2025)
The table below shows the annual net assets of Heartbeam Inc from 2003 to 2025. For live valuation and market cap data, see BEAT market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $2.60 Million | +57.38% |
| 2024-12-31 | $1.65 Million | -89.62% |
| 2023-12-31 | $15.94 Million | +571.31% |
| 2022-12-31 | $2.37 Million | -82.30% |
| 2021-12-31 | $13.41 Million | +380.25% |
| 2020-12-31 | $-4.79 Million | -28.39% |
| 2019-12-31 | $-3.73 Million | -101.20% |
| 2018-12-31 | $310.49 Million | +24.34% |
| 2017-12-31 | $249.70 Million | +79.75% |
| 2016-12-31 | $138.91 Million | +82.96% |
| 2015-12-31 | $75.93 Million | +19.24% |
| 2014-12-31 | $63.68 Million | -4.72% |
| 2013-12-31 | $66.83 Million | -4.53% |
| 2012-12-31 | $70.00 Million | -10.26% |
| 2011-12-31 | $78.00 Million | -42.19% |
| 2010-12-31 | $134.93 Million | -9.66% |
| 2009-12-31 | $149.35 Million | -0.51% |
| 2008-12-31 | $150.12 Million | +658.78% |
| 2007-12-31 | $-26.87 Million | -35.29% |
| 2006-12-31 | $-19.86 Million | -618.67% |
| 2004-12-31 | $-2.76 Million | -134.54% |
| 2003-12-31 | $8.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Heartbeam Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7728800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.00K | 0.15% |
| Other Components | $79.89 Million | 3069.04% |
| Total Equity | $2.60 Million | 100.00% |
Heartbeam Inc Competitors by Market Cap
The table below lists competitors of Heartbeam Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ginni Filaments Limited
NSE:GINNIFILA
|
$40.75 Million |
|
BrilliA Inc
NYSE MKT:BRIA
|
$40.75 Million |
|
EstechPharma Co. Ltd
KQ:041910
|
$40.76 Million |
|
Mirae Asset Global REIT Co. Ltd.
KO:396690
|
$40.80 Million |
|
Batavia Prosperindo Finance
JK:BPFI
|
$40.74 Million |
|
Lien Chang Electronic Enterprise Co Ltd
TW:2431
|
$40.71 Million |
|
Koan Hao Technology Co Ltd
TWO:8354
|
$40.70 Million |
|
Acorn Energy, Inc. Common Stock
NASDAQ:ACFN
|
$40.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Heartbeam Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,654,000 to 2,603,000, a change of 949,000 (57.4%).
- Net loss of 21,015,000 reduced equity.
- New share issuances of 16,578,000 increased equity.
- Other factors increased equity by 5,386,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-21.02 Million | -807.34% |
| Share Issuances | $16.58 Million | +636.88% |
| Other Changes | $5.39 Million | +206.92% |
| Total Change | $- | 57.38% |
Book Value vs Market Value Analysis
This analysis compares Heartbeam Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.84x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.23x to 9.84x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | $3.30 | $0.76 | x |
| 2004-12-31 | $-0.97 | $0.76 | x |
| 2006-12-31 | $-1.33 | $0.76 | x |
| 2007-12-31 | $-1.79 | $0.76 | x |
| 2008-12-31 | $6.63 | $0.76 | x |
| 2009-12-31 | $6.28 | $0.76 | x |
| 2010-12-31 | $5.60 | $0.76 | x |
| 2011-12-31 | $3.19 | $0.76 | x |
| 2012-12-31 | $2.81 | $0.76 | x |
| 2013-12-31 | $2.62 | $0.76 | x |
| 2014-12-31 | $2.41 | $0.76 | x |
| 2015-12-31 | $2.61 | $0.76 | x |
| 2016-12-31 | $4.56 | $0.76 | x |
| 2017-12-31 | $8.25 | $0.76 | x |
| 2018-12-31 | $8.68 | $0.76 | x |
| 2019-12-31 | $-0.46 | $0.76 | x |
| 2020-12-31 | $-0.59 | $0.76 | x |
| 2021-12-31 | $1.72 | $0.76 | x |
| 2022-12-31 | $0.29 | $0.76 | x |
| 2023-12-31 | $0.78 | $0.76 | x |
| 2024-12-31 | $0.06 | $0.76 | x |
| 2025-12-31 | $0.08 | $0.76 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Heartbeam Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -807.34%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 2.24x
- Recent ROE (-807.34%) is below the historical average (-131.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -158.50% | -160.04% | 0.36x | 2.77x | $-13.48 Million |
| 2004 | 0.00% | -94.22% | 0.97x | 0.00x | $-20.67 Million |
| 2006 | 0.00% | -22.54% | 1.98x | 0.00x | $-5.66 Million |
| 2007 | 0.00% | -0.49% | 0.71x | 0.00x | $2.33 Million |
| 2008 | 6.13% | 7.64% | 0.73x | 1.10x | $-5.81 Million |
| 2009 | -13.71% | -14.56% | 0.84x | 1.13x | $-35.41 Million |
| 2010 | -14.72% | -16.56% | 0.77x | 1.16x | $-33.35 Million |
| 2011 | -78.75% | -51.61% | 1.25x | 1.22x | $-69.22 Million |
| 2012 | -17.43% | -10.94% | 1.24x | 1.29x | $-19.20 Million |
| 2013 | -10.95% | -5.65% | 1.48x | 1.31x | $-14.00 Million |
| 2014 | -15.38% | -5.88% | 1.33x | 1.96x | $-16.16 Million |
| 2015 | 9.78% | 4.16% | 1.44x | 1.64x | $-164.60K |
| 2016 | 38.47% | 25.65% | 1.05x | 1.43x | $39.55 Million |
| 2017 | -6.36% | -5.56% | 0.55x | 2.09x | $-41.03 Million |
| 2018 | 13.79% | 10.72% | 0.68x | 1.89x | $11.77 Million |
| 2019 | 0.00% | -0.18% | 62729.57x | 0.00x | $-405.30K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-869.50K |
| 2021 | -33.02% | 0.00% | 0.00x | 1.04x | $-5.77 Million |
| 2022 | -540.31% | 0.00% | 0.00x | 1.70x | $-13.06 Million |
| 2023 | -91.86% | 0.00% | 0.00x | 1.07x | $-16.23 Million |
| 2024 | -1175.82% | 0.00% | 0.00x | 1.98x | $-19.61 Million |
| 2025 | -807.34% | 0.00% | 0.00x | 2.24x | $-21.28 Million |
Industry Comparison
This section compares Heartbeam Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $315,831,382
- Average return on equity (ROE) among peers: -43.50%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Heartbeam Inc (BEAT) | $2.60 Million | -158.50% | 1.24x | $40.74 Million |
| Aclarion Inc (ACON) | $2.23 Million | -317.55% | 0.31x | $1.82 Million |
| American Well Corp (AMWL) | $-204.41 Million | 0.00% | 0.00x | $126.97 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-540.52K | 0.00% | 0.00x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $784.08 Million | -6.88% | 5.94x | $10.63 Billion |
| Carlsmed, Inc. Common Stock (CARL) | $-70.63 Million | 0.00% | 0.00x | $273.75 Million |
| CareCloud, Inc. (CCLD) | $41.72 Million | -116.68% | 0.87x | $92.63 Million |
| Certara Inc (CERT) | $492.77 Million | -6.75% | 1.13x | $881.63 Million |
| CareMax Inc (CMAX) | $6.73 Million | 88.33% | 4.72x | $381.50 |
| Claritev Corporation (CTEV) | $1.79 Billion | -32.00% | 3.12x | $460.29 Million |
About Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection … Read more